ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesR87.62

R87.62

Abnormal cytological findings in specimens from vagina

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/11/2025

Code Description

ICD-10 R87.62 is a billable code used to indicate a diagnosis of abnormal cytological findings in specimens from vagina.

Key Diagnostic Point:

R87.62 refers to abnormal cytological findings in specimens obtained from the vagina, typically identified through Pap smears or other cytological examinations. These findings may indicate the presence of atypical cells, which can be benign or suggestive of precancerous changes or malignancy. Common symptoms associated with abnormal findings may include unusual vaginal discharge, bleeding, or discomfort. The clinical context often involves screening for cervical cancer or monitoring known lesions. Abnormal cytological results necessitate further diagnostic evaluation, including colposcopy and biopsy, to determine the underlying cause and appropriate management. The findings can be due to various factors, including infections (e.g., HPV), inflammation, or neoplastic changes. Accurate coding is essential for proper patient management and tracking of public health data related to cervical health.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variability in clinical presentation and underlying causes
  • Need for correlation with histological findings
  • Potential overlap with other gynecological conditions
  • Documentation requirements for abnormal findings

Audit Risk Factors

  • Inadequate documentation of the cytological findings
  • Failure to link abnormal findings to further diagnostic procedures
  • Misinterpretation of benign versus malignant findings
  • Inconsistent coding practices across providers

Specialty Focus

Medical Specialties

Internal Medicine

Documentation Requirements

Detailed documentation of symptoms, cytological findings, and follow-up plans is essential.

Common Clinical Scenarios

Routine screening results showing atypical squamous cells.

Billing Considerations

Consideration of patient history, including previous abnormal results and HPV vaccination status.

Emergency Medicine

Documentation Requirements

Acute care documentation should include presenting symptoms and any immediate interventions.

Common Clinical Scenarios

Patients presenting with abnormal vaginal bleeding or discharge.

Billing Considerations

Rapid assessment and documentation of any acute complications related to abnormal findings.

Coding Guidelines

Inclusion Criteria

Use R87.62 When
  • Follow the official ICD
  • CM guidelines for coding and reporting, ensuring that the code is used in conjunction with appropriate clinical documentation and any relevant procedural codes

Exclusion Criteria

Do NOT use R87.62 When
No specific exclusions found.

Related CPT Codes

88141CPT Code

Cytopathology, cervical or vaginal, screening

Clinical Scenario

Used when performing a Pap smear that results in abnormal findings.

Documentation Requirements

Document the type of specimen, findings, and any follow-up recommendations.

Specialty Considerations

Ensure that the procedure is linked to the diagnosis of abnormal cytological findings.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of abnormal cytological findings, improving data accuracy and patient management tracking.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of abnormal cytological findings, improving data accuracy and patient management tracking.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of abnormal cytological findings, improving data accuracy and patient management tracking.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What should I document when coding R87.62?

Document the specific cytological findings, any symptoms the patient presents with, and the follow-up plan, including any procedures scheduled.